We’re making news in the life science industry

Read our latest press releases to learn how Gel4Med is making an impact in the life science ecosystem.

July 9, 2024

Gel4Med Receives Recognition in Podiatry Today for their G4Derm™ Product Line as a Top 10 Innovation in Podiatry

Gel4Med, an innovative biomaterials company, is proud to announce that Podiatry Today has recognized their first product, G4Derm™ Plus, as one of the Top 10 Innovations in Podiatry.

May 01, 2024

Gel4Med and The Miami Project awarded significant funding from the CDMRP/DoD in a strategic collaboration to conduct groundbreaking spinal cord injury research

Gel4Med and University of Miami funded to collaborate and innovate around novel treatments for Spinal Cord Injury.

October 05, 2023

National Institutes of Health Commercial Readiness Pilot (CRP) program awards Gel4Med

The highly competitive National Institutes of Health Commercial Readiness Pilot (CRP) program awards Gel4Med with significant funding for the commercial launch of their lead asset.

October 23, 2023

FDA grants clearance to Gel4Med: Breakthroughs in wound management with G4Derm and G4Derm™ Plus

Wound healing is a long-term, multistage biological process that includes hemostasis...

For press and media inquires, please email bd@gelformed.com